LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

MLA

Kalpana M. Merchant, et al. “LRRK2 and GBA1 Variant Carriers Have Higher Urinary Bis(Monacylglycerol) Phosphate Concentrations in PPMI Cohorts.” Npj Parkinson’s Disease, vol. 9, no. 1, Feb. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41531-023-00468-2.

APA

Kalpana M. Merchant, Tanya Simuni, Janel Fedler, Chelsea Caspell-Garcia, Michael Brumm, Kelly N. H. Nudelman, Elizabeth Tengstrandt, Frank Hsieh, Roy N. Alcalay, Christopher Coffey, Lana Chahine, Tatiana Foroud, Andrew Singleton, Daniel Weintraub, Samantha Hutten, Todd Sherer, Brit Mollenhauer, Andrew Siderowf, Caroline Tanner, … the Parkinson’s Progression Markers Initiative. (2023). LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. Npj Parkinson’s Disease, 9(1), 1–10. https://doi.org/10.1038/s41531-023-00468-2

Chicago

Kalpana M. Merchant, Tanya Simuni, Janel Fedler, Chelsea Caspell-Garcia, Michael Brumm, Kelly N. H. Nudelman, Elizabeth Tengstrandt, et al. 2023. “LRRK2 and GBA1 Variant Carriers Have Higher Urinary Bis(Monacylglycerol) Phosphate Concentrations in PPMI Cohorts.” Npj Parkinson’s Disease 9 (1): 1–10. doi:10.1038/s41531-023-00468-2.